Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy.

The Pediatric Infectious Disease Journal
Katja DoerholtCollaborative HIV Paediatric Study

Abstract

There are few data about disease progression and response to antiretroviral therapy (ART) in vertically HIV-infected infants in the era of effective therapy. Cohort study. We examined progression to acquired immunodeficiency syndrome (AIDS) and death over calendar time for infants reported to the National Study of HIV in Pregnancy and Childhood in the United Kingdom/Ireland. The use of ART and CD4 and HIV-1 RNA responses were assessed in a subset in the Collaborative HIV Pediatric Study. Among 481 infants, mortality was lower in those born after 1997 (HR 0.30; P < 0.001), with no significant change in progression to AIDS. Of 174 infants born since 1997 in the Collaborative HIV Pediatric Study, 41 (24%) were followed from birth, 77 (44%) presented pre-AIDS and 56 (32%) presented with AIDS. Of 125 (72%) children on 3- or 4-drug ART by the age of 2 years, 59% had HIV-1 RNA <400 at 12 months; median CD4 percentage increased from 24% to 35%. Among 41 infants followed from birth, 12 progressed to AIDS (5 while ART naive) and 3 died; 1 of 10 infants initiating ART before 3 months of age progressed clinically. Mortality in HIV-infected infants is significantly lower in the era of effective ART, but symptomatic disease rates remain high...Continue Reading

References

Aug 1, 1994·The Journal of Clinical Investigation·G S WorthenG L Johnson
May 15, 1993·BMJ : British Medical Journal·A E AdesC S Peckham
Apr 15, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S BlancheC S Peckham
Jan 6, 1999·AIDS·G B Scott, R Tuomala
Nov 8, 2001·AIDS·A M van RossumUNKNOWN Dutch Study Group for Children with HIV Infections
Jan 17, 2002·The New England Journal of Medicine·S L GortmakerUNKNOWN Pediatric AIDS Clinical Trials Group Protocol 219 Team
Aug 17, 2002·The Pediatric Infectious Disease Journal·Albert FayeUNKNOWN French Perinatal Study
Nov 1, 2003·BMJ : British Medical Journal·D M GibbUNKNOWN National Study of HIV in Pregnancy and Childhood Collaborative HIV Paediatric Study
Nov 25, 2003·Lancet·David Dunn, UNKNOWN HIV Paediatric Prognostic Markers Collaborative Study Group
Dec 12, 2003·The New England Journal of Medicine·Robert W ShaferUNKNOWN AIDS Clinical Trials Group 384 Team
Jun 11, 2004·The New England Journal of Medicine·Katherine LuzuriagaUNKNOWN PACTG 356 Investigators
Jul 9, 2004·HIV Medicine·M SharlandUNKNOWN PENTA Steering Committee
Sep 9, 2004·AIDS·A Sarah WalkerUNKNOWN Collaborative HIV Paediatric Study (CHIPS) Steering Committee
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Albert FayeUNKNOWN French Perinatal Study Group
May 12, 2005·JAMA : the Journal of the American Medical Association·David R BerkUNKNOWN California Pediatric HIV Study Group

❮ Previous
Next ❯

Citations

Feb 25, 2009·The Journal of Infectious Diseases·Nazma MansoorWillem A Hanekom
Nov 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrea L CiaranelloRochelle P Walensky
Oct 18, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bill G KapogiannisMarc Bulterys
Dec 27, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tessa GoetghebuerUNKNOWN European Infant Collaboration Group
Jan 27, 2010·International Journal of Epidemiology·Azar KariminiaVirat Sirisanthana
Jun 25, 2008·The Pediatric Infectious Disease Journal·Rachel C VreemanWinstone M Nyandiko
Jul 11, 2008·AIDS·UNKNOWN Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study GroupJens Lundgren
Feb 6, 2009·AIDS·Tessa GoetghebuerUNKNOWN European Infant Collaboration group
Dec 26, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael T BradyUNKNOWN Pediatric AIDS Clinical Trials Group219/219C Team
May 2, 2009·Current Opinion in Infectious Diseases·Ravindra K GuptaDeenan Pillay
Nov 3, 2009·HIV Medicine·UNKNOWN PENTA Steering CommitteeDiane Bastiaans
Jul 23, 2009·Annual Review of Medicine·Rohan HazraLynne M Mofenson
Oct 30, 2008·AIDS Research and Therapy·Jintanat AnanworanichUNKNOWN HIV-NAT 010 Study Team
Jan 26, 2011·Pediatrics·Elizabeth Peacock-VilladaGrace C John-Stewart
May 16, 2008·Clinical Drug Investigation·Carlo GiaquintoRuggero D'Elia
Nov 29, 2012·International Journal of Behavioral Medicine·Rachel C VreemanThomas S Inui
Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ali JuddUNKNOWN National Study of HIV in Pregnancy and Childhood (NSHPC)
Nov 28, 2014·Journal of the International AIDS Society·Rachel C VreemanThomas S Inui
Mar 23, 2010·Journal of the International AIDS Society·Petros IsaakidisRony Zachariah
Nov 26, 2010·BMC Pediatrics·Saboura MahdaviUNKNOWN Ukraine European Collaborative Study Group
Aug 21, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Rachel C VreemanTerry F Blaschke
Dec 2, 2009·Qualitative Health Research·Rachel C VreemanThomas S Inui
Sep 5, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Rachel C VreemanWinstone M Nyandiko
Aug 19, 2007·Scandinavian Journal of Infectious Diseases·Linda BracherNiels Obel
Mar 8, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Winstone NyandikoPaula Braitstein
Jun 5, 2014·Cadernos de saúde pública·Gabriela Ricordi BazinClaudete Aparecida Araújo Cardoso
Apr 21, 2009·The Medical Journal of Australia·Ann M McDonaldJohn M Kaldor
Jul 26, 2008·The Lancet Infectious Diseases·Catherine G SutcliffeWilliam J Moss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.